Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
 
 
February 21, Wednesday 2018 6:19 AM       

       HEADLINES: SC likely to hear Priya Varrier's plea today                                              Youth commits suicide by jumping into backwater                                              CM doesn’t relent, Private bus operators finally give up strike                                              CPM has turned into terror group: Chennithala                                              No intention to reveal name of minister who kissed my palm: Former PRD official                                              I'm in politics because AIADMK is bad: Kamal Haasan                                              AAP MLAs allegedly assault Delhi Chief Secretary in CM’s presence                                              Kothari not detained, but being questioned: CBI                                              Kamal Haasan to visit Rameswaram, launch party on Wednesday                                              Regime forces kill 77 in Syria                                              Explosion in Jalalabad kills three                                              Khaleda Zia case: No trust existed when grant came in 1991                                              Sardar Singh to lead India in Sultan Azlan Shah Hockey Cup                                              I-League: Minerva face daunting task against Gokulam                                              Federer starts fourth stint as World No.1                                              Kaumudi Facebook
       SCI&TECH Next Article: Water exists deeper in Earth than thought: study  
       New potent vaccine may spell end for HIV
 
         Posted on :16:07:12 Nov 28, 2016
   
A A
       Last edited on:16:07:12 Nov 28, 2016
         Tags: New potent vaccine, HIV
 
WASHINGTON: The largest and most advanced HIV vaccine trial has been launched in South Africa to test the safety of a new experimental regimen that could prove to be the final nail in the coffin for the deadly virus.
 
The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus.
 
It aims to enroll 5,400 men and women, making it the where more than 1,000 people become infected with HIV every day.
 
"If deployed alongside our current armory of proven HIV prevention tools, a safe and effective vaccine could be the final nail in the coffin for HIV," said Anthony S Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID).
 
"Even a moderately effective vaccine would significantly decrease the burden of HIV disease over time in countries and populations with high rates of HIV infection, such as South Africa," said Fauci.
 
The HIV Vaccine Trials Network (HVTN) is conducting the trial at 15 sites across South Africa. Results are expected in late 2020.
 
The experimental vaccine regimen being tested in the trial is based on the one investigated in the earlier RV144 clinical trial in Thailand led by the US Military HIV Research Programme and the Thai Ministry of Health.
 
The Thai trial delivered landmark results in 2009 when it found for the first time that a vaccine could prevent HIV infection, albeit modestly.
 
The new regimen aims to provide greater and more sustained protection than the RV144 regimen and has been adapted to the HIV subtype that predominates in southern Africa, a region that includes the country of South Africa.
 
"The people of South Africa are making history by conducting and participating in the first HIV vaccine efficacy study to build on the results of the Thai trial," said Glenda Gray, CEO of the South African Medical Research Council.
 
"HIV has taken a devastating toll in South Africa, but now we begin a scientific exploration that could hold great promise for our country," Gray said, who is also a professor at the University of the Witwatersrand.
 
"If an HIV vaccine were found to work in South Africa, it may dramatically alter the course of the pandemic," she said. The experimental vaccine regimen tested in the Thai trial was found to be 31.2 per cent effective at preventing HIV infection over the 3.5-year follow-up after vaccination.
 
In the HVTN 702 study, the design, schedule and components of the RV144 vaccine regimen have been modified in an attempt to increase the magnitude and duration of vaccine-elicited protective immune responses.
 
HVTN 702 begins just months after interim results were reported for HVTN 100, its predecessor clinical trial, which found that the new vaccine regimen was safe for the 252 study participants and induced comparable immune responses to those reported in RV144. 
A A
       SCI&TECH
Next Article: Water exists deeper in Earth than thought: study
 
 
SCI&TECH HEADLINES
Ensuring sexual, reproductive health for overall well-being  
WeChat gets popular in Bhutan: report  
Celebrate love this Valentine's Day with Google Pixel 2  
This drug could reverse alcohol's damaging effects on brain  
Scientists discover enormous reserves of mercury in permafrost  
Google Assistant helps you set music alarms  
What is epilepsy?  
Here're some ways to keep dementia at bay  
What are memories made of?  
Second-hand plastic toys could harm your kid  
Working before and after stroke is good for brain health  
ixigo introduces India's first augmented reality feature for Train Passengers  
Super blue moon on Jan. 31 will mark last of trilogy  
Now, a blood test that can screen eight cancer types  
Secret of longevity protein revealed!  
Absence of this gene can give men deadly cancer  
Soon, you can demote group admins on WhatsApp  
Regular yoga can slow down ageing of brain: Study  
What are haemorrhoids (piles) and what causes them?  
WhatsApp facilitates quick switch from voice to video call  
The Thin and Light Lenovo Ideapad 720s shines at Digit Zero 1 Awards  
Frequent heartburns up cancer risk in older adults  
Blueberry vinegar can help fight dementia  
iPhones with older batteries will take a hit in performance: Apple  
Eighth planet found in faraway solar system, matching ours  
 
Do you think the arrested persons in Shuhaib murder case are real culprits?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy